All the information you need about EUROFINS BIOLOGIE MEDICALE ILE DE FRANCE to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-06-27 | Public | 2021-12-31 | Complete |
| 2021-12-31 | Public | 2020-12-31 | Complete |
| 2020-08-11 | Public | 2019-12-31 | Complete |
| 2019-10-16 | Public | 2018-12-31 | Complete |
| Name | EUROFINS BIOLOGIE MEDICALE ILE DE FRANCE |
| Siren | 841286180 |
| Closing | 2018-12-31 |
| Registry code | 6901 |
| Registration number | B2019/046533 |
| Management number | 2018B04870 |
| Activity code | 7022Z |
| Closing date n-1 | 1901-01-01 |
| Duration Fiscal year | 05 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2019-10-16 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 69003 LYON 3EME |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BJ TOTAL (I) | 65 983 129.00 | 65 983 129.00 | 65 983 129.00 | |
CF Cash and cash equivalents | 5 364.00 | 5 364.00 | 5 364.00 | |
CJ TOTAL (II) | 5 364.00 | 5 364.00 | 5 364.00 | |
CO Grand total (0 to V) | 65 988 493.00 | 65 988 493.00 | 65 988 493.00 | |
CU Other investments | 65 983 129.00 | 65 983 129.00 | 65 983 129.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 61 286 622.00 | 5.00 | 61 286 622.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | -103 832.00 | -103 832.00 | ||
DL TOTAL (I) | 61 182 790.00 | 61 182 790.00 | ||
DX Trade payables and related accounts | 9 000.00 | 9 000.00 | ||
EA Other liabilities | 4 796 703.00 | 4 796 703.00 | ||
EC TOTAL (IV) | 4 805 703.00 | 4 805 703.00 | ||
EE Grand total (I to V) | 65 988 493.00 | 65 988 493.00 | ||
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 9 036.00 | |||
FX Taxes, duties, and similar payments | 66 009.00 | |||
GF Total Operating Expenses (II) | 75 045.00 | |||
GG - OPERATING RESULT (I - II) | -75 045.00 | |||
GR Interest and similar expenses | 28 787.00 | |||
GU Total financial expenses (VI) | 28 787.00 | |||
GV - FINANCIAL INCOME (V - VI) | -28 787.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -103 832.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 103 832.00 | 103 832.00 | ||
HN PROFIT OR LOSS (Total revenue - Total expenses) | -103 832.00 | -103 832.00 | ||
| 5 - Fixed assets increase - decrease | Gross value at beginning of year - Item by item | Revaluation - Disposals | Acquisition - Gross value at year-end | |
0G ACQUISITIONS Total General Total | 65 983 129.00 | |||
I3 DECREASES Total Financial Fixed Assets | 65 983 129.00 | |||
I4 DECREASES Grand Total | 65 983 129.00 | |||
LQ ACQUISITIONS Total Financial Fixed Assets | 65 983 129.00 | |||
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 9 000.00 | 9 000.00 | 9 000.00 | |
VI Group and Associates | 4 796 703.00 | 28 788.00 | 4 767 916.00 | 4 796 703.00 |
VY TOTAL – STATEMENT OF LIABILITIES | 4 805 703.00 | 37 788.00 | 4 767 916.00 | 4 805 703.00 |
